We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? (Pagedocc1)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified September 2010 by University of Paris 5 - Rene Descartes.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01279278
First Posted: January 19, 2011
Last Update Posted: January 19, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Adeca 75
Société de Formation Thérapeutique du Généraliste
Hotel Dieu Hospital
Information provided by:
University of Paris 5 - Rene Descartes
January 18, 2011
January 19, 2011
January 19, 2011
September 2010
April 2011   (Final data collection date for primary outcome measure)
Completion of Fecal Occult Blod Test [ Time Frame: 7 months ]
Increased number of patients who completed the test for faecal occult blood following the first solicitation with the letter co-signed by general practitioner, compared with the conventional solicition(including replies exclusions).
Same as current
No Changes Posted
  • Measure the impact of co-signing on deadline for completion of the test after the mailing. [ Time Frame: 7 months ]
  • Compare the proportion of uninterpretable tests. [ Time Frame: 7 months ]
  • Compare the rate of completion of colonoscopy after a positive test (information received by ADECA in the follow-up), according to the specifications. [ Time Frame: 7 months ]
Same as current
Not Provided
Not Provided
 
Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening? A Cluster Randomised Controlled Study.
The propose of this study is to assess the effect of general practitioner's involvement on first patients' solicitation in screening for colorectal cancer by testing for faecal occult blood (FOBT).
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Screening
Colorectal Cancer
  • Other: Co-signed letter
    Patients receive a personalized letter co-signed by their general practitioner and the medical coordinator of ADECA.
  • Other: Classical Letter
    Patients receive classical letter signed by the coordinator doctor of ADECA
  • No Intervention: Control
    Intervention: Other: Classical Letter
  • Experimental: Co-signed Letter
    Intervention: Other: Co-signed letter
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
2700
April 2011
April 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Aged : 50 to 74 years.
  • Not having ever been invited to participate in colorectal screening.

Exclusion Criteria:

  • Patients who have a Fecal Occult Blood Test for less than 2 years or a colonoscopy within the past 5 years or excluded for medical reasons (according to information known from ADECA).
Sexes Eligible for Study: All
50 Years to 74 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT01279278
PAGEDOCC1
Yes
Not Provided
Not Provided
Pr Serge Gilberg, Université Paris Descartes - Département de Médecine Générale
University of Paris 5 - Rene Descartes
  • Adeca 75
  • Société de Formation Thérapeutique du Généraliste
  • Hotel Dieu Hospital
Not Provided
University of Paris 5 - Rene Descartes
September 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP